The global medical plastic compounds market size is expected to hit around USD 79.56 billion by 2027 and progressing a CAGR of 5.4% over the forecast period 2020 to 2027.
The on medical
plastic compounds Market, which provides a business strategy, research &
development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1155
Report Scope of the Medical Plastic Compounds Market
Report Highlights | Details |
Market Size | USD 79.56 Billion by 2027 |
Growth Rate | CAGR of 5.4% from 2021 to 2027 |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2021 to 2027 |
Segments Covered | Product, Application, Region |
A recent
report provides crucial insights along with application based and forecast
information in the Global Medical plastic compounds Market. The report provides
a comprehensive analysis of key factors that are expected to drive the growth
of this market. This study also provides a detailed overview of the
opportunities along with the current trends observed in the Medical plastic
compounds market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Medical plastic compounds
market are included as given below:
Medical plastic compounds Market Key Players
- Nolato AB
- Freudenberg Medical LLC
- Rochling Group
- GW Plastics Inc.
- MedPlast Inc.
- Phillips Medisisze Corporation
- C&J Industries Inc.
- Tekni-Plex, Inc.
- Pexco LLC
- Medical Plastic Devices Inc.
Market Segments
- Polyethylene
- Polyvinylchloride
- Polypropylene
- Polyester
- Polystyrene
- Polycarbonate
- Acrylics
- Polyurethane
- Others
By Application
- Catheters
- Disposables
- Drug Delivery System
- Surgical Instruments
- Implants
- Medical Bags
- Others
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Report Objectives
- To define, describe, and forecast the global medical
plastic compounds market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the medical
plastic compounds market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Medical Plastic Compounds Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Plastic Compounds Market
5.1. Covid-19: Medical Plastic Compounds Industry Impact
5.2. Medical Plastic Compounds Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Medical Plastic Compounds Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Medical Plastic Compounds Manufacturers to deal with Covid-19 Pandemic Scenario
Chapter 6. Medical Plastic Compounds Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Prevalence of Chronic Disease
6.1.1.2. Rising Consumption of Polymers in Healthcare Industry
6.1.2. Market Restraints
6.1.2.1. Volatile Prices of Raw Materials
6.1.3. Market Opportunities
6.1.3.1. Increasing Research Activities to Develop Advanced Medical Grade Plastics
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Global Medical Plastic Compounds Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Medical Plastic Compounds Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Medical Plastic Compounds Market Revenue Market Share by Manufacturer (2015-2020)
7.1.1.3. Medical Plastic Compounds Market Production by Manufacturer (2015-2020)
7.1.1.4. Medical Plastic Compounds Market Production Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Manufacturers Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Plastic Compounds Market, By Product
8.1. Medical Plastic Compounds Market, by Product, 2016-2027
8.1.1. Polyethylene
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.1.2. Market Production and Forecast (2016-2027)
8.1.2. Polyvinylchloride
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.2.2. Market Production and Forecast (2016-2027)
8.1.3. Polypropylene
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.3.2. Market Production and Forecast (2016-2027)
8.1.4. Polyester
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.4.2. Market Production and Forecast (2016-2027)
8.1.5. Polystyrene
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.5.2. Market Production and Forecast (2016-2027)
8.1.6. Polycarbonate
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.6.2. Market Production and Forecast (2016-2027)
8.1.7. Acrylics
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.7.2. Market Production and Forecast (2016-2027)
8.1.8. Polyurethane
8.1.8.1. Market Revenue and Forecast (2016-2027)
8.1.8.2. Market Production and Forecast (2016-2027)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2016-2027)
8.1.9.2. Market Production and Forecast (2016-2027)
Chapter 9. Global Medical Plastic Compounds Market, By Application
9.1. Medical Plastic Compounds Market, by Application, 2016-2027
9.1.1. Catheters
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.1.2. Market Consumption and Forecast (2016-2027)
9.1.2. Disposables
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.2.2. Market Consumption and Forecast (2016-2027)
9.1.3. Drug Delivery System
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.3.2. Market Consumption and Forecast (2016-2027)
9.1.4. Surgical Instruments
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.4.2. Market Consumption and Forecast (2016-2027)
9.1.5. Implants
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.5.2. Market Consumption and Forecast (2016-2027)
9.1.6. Medical Bags
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.6.2. Market Consumption and Forecast (2016-2027)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2016-2027)
9.1.7.2. Market Consumption and Forecast (2016-2027)
Chapter 10. Global Medical Plastic Compounds Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Production Forecast by Product (2016-2027)
10.1.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue and Production Forecast (2016-2027)
10.1.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue and Production Forecast (2016-2027)
10.1.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Production Forecast by Product (2016-2027)
10.2.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue and Production Forecast (2016-2027)
10.2.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue and Production Forecast (2016-2027)
10.2.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue and Production Forecast (2016-2027)
10.2.5.2. Market Revenue and Consumption Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue and Production Forecast (2016-2027)
10.2.6.2. Market Revenue and Consumption Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue and Production Forecast by Product (2016-2027)
10.3.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue and Production Forecast (2016-2027)
10.3.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Production Forecast (2016-2027)
10.3.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue and Production Forecast (2016-2027)
10.3.5.2. Market Revenue and Consumption Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Production Forecast (2016-2027)
10.3.6.2. Market Revenue and Consumption Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue and Production Forecast by Product (2016-2027)
10.4.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue and Production Forecast (2016-2027)
10.4.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue and Production Forecast (2016-2027)
10.4.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue and Production Forecast by Product (2016-2027)
10.5.2. Market Revenue and Consumption Forecast by Application (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue and Production Forecast (2016-2027)
10.5.3.2. Market Revenue and Consumption Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue and Production Forecast (2016-2027)
10.5.4.2. Market Revenue and Consumption Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue and Production Forecast (2016-2027)
10.5.5.2. Market Revenue and Consumption Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue and Production Forecast (2016-2027)
10.5.6.2. Market Revenue and Consumption Forecast (2016-2027)
Chapter 11. Company Profiles
11.1. Nolato AB
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Freudenberg Medical LLC
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Rochling Group
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. GW Plastics Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. MedPlast Inc.
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. Phillips Medisisze Corporation
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. C&J Industries Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Tekni-Plex, Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Pexco LLC
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Medical Plastic Devices Inc.
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Production Capacity, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments